Unknown

Dataset Information

0

MiR-3606-3p inhibits systemic sclerosis through targeting TGF-? type II receptor.


ABSTRACT: Systemic sclerosis (SSc) is a multisystemic fibrotic disease characterized by excessive collagen deposition and extracellular matrix synthesis. Though transforming growth factor-? (TGF-?) plays a fundamental role in the pathogenesis of SSc, the mechanism by which TGF-? signaling acts in SSc remains largely unclear. Here, we showed that TGF-? type II receptor (TGFBR2) was significantly upregulated in both human SSc dermal tissues and primary fibroblasts. In fibroblasts, siRNA-induced knockdown of TGFBR2 resulted in a reduction of p-SMAD2/3 levels and reduced production of type I collagen. Additionally, functional experiments revealed that downregulation of TGFBR2 yielded an anti-growth effect on fibroblasts through inhibiting cell cycle progression. Further studies showed that miR-3606-3p could directly target the 3'-UTR of TGFBR2 and significantly decrease the levels of both TGFBR2 mRNA and protein. Furthermore, SSc dermal tissues and primary fibroblasts contain significantly reduced amounts of miR-3606-3p, and the overexpression of miR-3606-3p in fibroblasts replicates the phenotype of TGFBR2 downregulation. Collectively, our findings demonstrated that increased TGFBR2 could be responsible for the hyperactive TGF-? signaling observed in SSc. Moreover, we identified a pivotal role for miR-3606-3p in SSc, which acts, at least partly, through the attenuation of TGF-? signaling via TGFBR2 repression, suggesting that the regulation of miR-3606-3p/TGFBR2 could be a promising therapeutic target that could improve the treatment strategy for fibrosis.

SUBMITTER: Shi X 

PROVIDER: S-EPMC6224271 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.

Shi Xiangguang X   Liu Qingmei Q   Li Na N   Tu Wenzhen W   Luo Ruoyu R   Mei Xueqian X   Ma Yanyun Y   Xu Weihong W   Chu Haiyan H   Jiang Shuai S   Du Zhimin Z   Zhao Han H   Zhao Liang L   Jin Li L   Wu Wenyu W   Wang Jiucun J  

Cell cycle (Georgetown, Tex.) 20180917 16


Systemic sclerosis (SSc) is a multisystemic fibrotic disease characterized by excessive collagen deposition and extracellular matrix synthesis. Though transforming growth factor-β (TGF-β) plays a fundamental role in the pathogenesis of SSc, the mechanism by which TGF-β signaling acts in SSc remains largely unclear. Here, we showed that TGF-β type II receptor (TGFBR2) was significantly upregulated in both human SSc dermal tissues and primary fibroblasts. In fibroblasts, siRNA-induced knockdown of  ...[more]

Similar Datasets

| S-EPMC4838850 | biostudies-literature
| S-EPMC7214999 | biostudies-literature
| S-EPMC5363213 | biostudies-literature
| S-EPMC3934598 | biostudies-literature
| S-EPMC8619113 | biostudies-literature
| S-EPMC7438898 | biostudies-literature
| S-EPMC6496930 | biostudies-literature
| S-EPMC11362518 | biostudies-literature
| S-EPMC6935118 | biostudies-literature
| S-EPMC9771326 | biostudies-literature